Fortress Biotech, Inc. (FBIO) vs InterCure Ltd. (INCR)

A side-by-side comparison of Fortress Biotech, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIO vs INCR

growth of $100 · dividends reinvested · last 8y
FBIO -90.3% (-25.3%/yr)INCR -68.0% (-13.3%/yr)INCR compounded faster over this window
0100200300Start $100202120232025$10$32
FBIO INCR

FBIO vs INCR: by the numbers

  • •FBIO is the larger company ($68M vs $65M market cap).
  • •FBIO is profitable (163.32% net margin) while INCR runs a net loss (-13.72%).
  • •INCR grew revenue faster over the past five years (32.71% vs 5.39% CAGR).

Metrics side by side

Valuation

MetricFBIOINCR
P/E ratio0.76N/A
P/S ratio0.990.81
P/B ratio0.410.52
FCF yield186.15%11.37%

Profitability

MetricFBIOINCR
Gross margin62.53%14.40%
Operating margin-111.00%2.49%
Net margin163.32%-13.72%
ROE68.12%-8.80%
ROIC-10.85%-4.72%

Growth (annualized)

MetricFBIOINCR
Revenue CAGR (5Y)5.39%32.71%
Total return CAGR (5Y)-46.06%-30.85%

Frequently asked

Which has grown faster, FBIO or INCR?
Over the past five years, INCR grew revenue faster — FBIO at a 5.39% CAGR versus INCR at 32.71%.
Is FBIO or INCR more profitable?
FBIO runs the higher net margin — FBIO at 163.32% versus INCR at -13.72%.
How have FBIO and INCR total returns compared?
Over the past 5 years, FBIO delivered -46.06% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.